Matthew Burow

Department of Medicine, Tulane University School of Medicine

Affiliated withTulane University School of Medicine

Research Area

Biography

Matthew Burow has not added Biography.
If you are Matthew Burow and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2021

Other Publications

Article	Year
Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery\| PubMed ID: 12219026	2002
Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. International journal of oncology\| PubMed ID: 15138590	2004
PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. International journal of oncology\| PubMed ID: 15703835	2005
p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor... Molecular endocrinology (Baltimore, Md.)\| PubMed ID: 16410316	2006
Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection. Antimicrobial agents and chemotherapy\| PubMed ID: 17923491	2007
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis. Breast cancer research and treatment\| PubMed ID: 18855134	2009
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast cancer research : BCR\| PubMed ID: 19087274	2008
Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP. Molecular carcinogenesis\| PubMed ID: 19263441	2009
Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system. Experimental biology and medicine (Maywood, N.J.)\| PubMed ID: 19546354	2009
Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. Journal of medicinal chemistry\| PubMed ID: 19694470	2009
Systems genetics analyses predict a transcription role for P2P-R: molecular confirmation that P2P-R is a transcriptional co-repressor. BMC systems biology\| PubMed ID: 20184719	2010
Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. International journal of oncology\| PubMed ID: 20664923	2010
Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells. Journal of medicinal chemistry\| PubMed ID: 20669983	2010
Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology\| PubMed ID: 20861237	2010
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast cancer research : BCR\| PubMed ID: 21167057	2010
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer biology & therapy\| PubMed ID: 21307639	2011
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer. Journal of molecular endocrinology\| PubMed ID: 21321095	2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer research\| PubMed ID: 21622715	2011
MEK5/ERK5 pathway: the first fifteen years. Biochimica et biophysica acta\| PubMed ID: 22020294	2012
Glyceollin-elicited soy protein consumption induces distinct transcriptional effects as compared to standard soy protein. Journal of agricultural and food chemistry\| PubMed ID: 22126086	2012
Environmental signaling and reproduction: a comparative biological and chemical perspective. Molecular and cellular endocrinology\| PubMed ID: 22178089	2012
Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast cancer research : BCR\| PubMed ID: 22417809	2012
Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance. Oncology reports\| PubMed ID: 22469881	2012
The microRNA expression associated with morphogenesis of breast cancer cells in three-dimensional organotypic culture. Oncology reports\| PubMed ID: 22576799	2012
The organochlorine o,p'-DDT plays a role in coactivator-mediated MAPK crosstalk in MCF-7 breast cancer cells. Environmental health perspectives\| PubMed ID: 22609851	2012
Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation. Cancer biology & therapy\| PubMed ID: 22825349	2012
Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance. Scientific reports\| PubMed ID: 22844580	2012
Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer. Experimental biology and medicine (Maywood, N.J.)\| PubMed ID: 22859737	2012
In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models. Journal of health care for the poor and underserved\| PubMed ID: 23395947	2013
Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition. International journal of oncology\| PubMed ID: 23403951	2013
Discovery of a Series of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion. ACS medicinal chemistry letters\| PubMed ID: 23526571	2013
MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis. PloS one\| PubMed ID: 23950888	2013
Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast cancer research : BCR\| PubMed ID: 24176089	2013
Design, synthesis, and osteogenic activity of daidzein analogs on human mesenchymal stem cells. ACS medicinal chemistry letters\| PubMed ID: 24900787	2014
Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival. Pharmacological reports : PR\| PubMed ID: 24905325	2014
Effects of the endocrine-disrupting chemical DDT on self-renewal and differentiation of human mesenchymal stem cells. Environmental health perspectives\| PubMed ID: 25014179	2015
Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells. Journal of molecular endocrinology\| PubMed ID: 25143472	2014
Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent me... Stem cell research & therapy\| PubMed ID: 25168698	2014
Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells. Stem cells (Dayton, Ohio)\| PubMed ID: 25267443	2015
microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity. Molecular cancer\| PubMed ID: 25283550	2014
Elevated expression of long intergenic non-coding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cells. Molecular carcinogenesis\| PubMed ID: 25328122	2015
Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer. The Journal of steroid biochemistry and molecular biology\| PubMed ID: 25771071	2015
Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast cancer research : BCR\| PubMed ID: 26286584	2015
A novel gastrointestinal microbiome modulator from soy pods reduces absorption of dietary fat in mice. Obesity (Silver Spring, Md.)\| PubMed ID: 26584538	2016
Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1. International journal of environmental research and public health\| PubMed ID: 26703648	2015
Induction of HOXA9 expression in three-dimensional organotypic culture of the Claudin-low breast cancer cells. Oncotarget\| PubMed ID: 27409175	2016
Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology. Molecular and cellular endocrinology\| PubMed ID: 28012841	2017
The Effects of Endocrine Disruptors on Adipogenesis and Osteogenesis in Mesenchymal Stem Cells: A Review. Frontiers in endocrinology\| PubMed ID: 28119665	2016
Oncogenic signaling of MEK5-ERK5. Cancer letters\| PubMed ID: 28153789	2017
Osteoinductive effects of glyceollins on adult mesenchymal stromal/stem cells from adipose tissue and bone marrow. Phytomedicine : international journal of phytotherapy and phytopharmacology\| PubMed ID: 28314478	2017
Glycinol enhances osteogenic differentiation and attenuates the effects of age on mesenchymal stem cells. Regenerative medicine\| PubMed ID: 28718749	2017
Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression. Molecular cancer research : MCR\| PubMed ID: 28751463	2017
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy. Current medicinal chemistry\| PubMed ID: 28875842	2019
A novel patient-derived xenograft model for claudin-low triple-negative breast cancer. Breast cancer research and treatment\| PubMed ID: 29392581	2018
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models. Oncotarget\| PubMed ID: 29467940	2018
Obesity Enhances the Conversion of Adipose-Derived Stromal/Stem Cells into Carcinoma-Associated Fibroblast Leading to Cancer Cell Proliferation and Progression to an Invasive Phenotype. Stem cells international\| PubMed ID: 29527228	2017
Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation. Non-coding RNA\| PubMed ID: 29657266	2016
Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model. Oncoscience\| PubMed ID: 29854878	2018
Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways. Frontiers in oncology\| PubMed ID: 30564555	2018
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. BMC cancer\| PubMed ID: 30845999	2019
Obesity-Altered Adipose Stem Cells Promote ER⁺ Breast Cancer Metastasis through Estrogen Independent Pathways. International journal of molecular sciences\| PubMed ID: 30897853	2019
Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs. Molecular pharmacology\| PubMed ID: 31221824	2019
Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer. Journal of cellular biochemistry\| PubMed ID: 31464004	2020
Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer. Scientific reports\| PubMed ID: 32483202	2020
A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify... Anti-cancer drugs\| PubMed ID: 32796402	2020
ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer. Frontiers in oncology\| PubMed ID: 32850332	2020
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PloS one\| PubMed ID: 33035223	2020
Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling. Biomolecules\| PubMed ID: 33572742	2021
Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review. Current medicinal chemistry\| PubMed ID: 33749548	2021
Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer. Translational oncology\| PubMed ID: 33761370	2021
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cell... Oncology letters\| PubMed ID: 33777204	2021
Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer. Women's health reports (New Rochelle, N.Y.)\| PubMed ID: 33786503	2020
EVALUATION OF EXTRACELLULAR MATRIX COMPOSITION TO IMPROVE BREAST CANCER MODELING. Tissue engineering. Part A\| PubMed ID: 33797977	2021
Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation. Journal of cellular biochemistry\| PubMed ID: 33876843	2021